Literature DB >> 6101958

Effect of heparin administration on plasma binding of benzodiazepines.

P V Desmond, R K Roberts, A J Wood, G D Dunn, G R Wilkinson, S Schenker.   

Abstract

1 The effect of intravenous administration of 100 units of heparin on plasma of diazepam, chlordiazepoxide, oxazepam and lorazepam was examined in fourteen normal subjects and five patients with cirrhosis. 2 In normal non-fasted subjects heparin caused a rapid 150--250% rise in the free fraction of diazepam, chlordiazepoxide and oxazepam but no change of lorazepam. The changes in free fraction were slightly smaller, but still significant, when the subjects were fasted. 3 These change in free fraction occurred within 90 s of administration of heparin and binding had returned to baseline by 30 to 45 min. 4 In the cirrhotic subjects the response to heparin was variable. 5 The use of heparin during drug disposition studies may affect the estimation of pharmacokinetic parameters and possibly pharmacological effects which are dependent on the circulating unbound drug level.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101958      PMCID: PMC1429863          DOI: 10.1111/j.1365-2125.1980.tb05829.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Effect of salicylic acid on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia.

Authors:  S Oie; G Levy
Journal:  J Pharm Sci       Date:  1979-01       Impact factor: 3.534

3.  Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.

Authors:  M Wood; D G Shand; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

4.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

5.  Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.

Authors:  D Rudman; T J Bixler; A E Del Rio
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

6.  Drug displacement from protein binding: isolation of a redistributional drug interaction in vivo.

Authors:  E G McQueen; W M Wardell
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

7.  More on heparin lock.

Authors:  N H Holford; S Vozeh; P Coates; J R Powell; J F Thiercelin; R Upton
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

Review 8.  Lipoprotein lipase.

Authors:  T Olivecrona; O Hernell; T Egelrud
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

9.  Plasma long chain fatty acids and esterified lipids in cirrhosis and hepatic encephalopathy.

Authors:  H G Wilcox; G D Dunn; S Schenker
Journal:  Am J Med Sci       Date:  1978 Nov-Dec       Impact factor: 2.378

10.  Blood collection techniques, heparin and quinidine protein binding.

Authors:  K M Kessler; R C Leech; J F Spann
Journal:  Clin Pharmacol Ther       Date:  1979-02       Impact factor: 6.875

View more
  11 in total

1.  Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.

Authors:  James M Chamberlain; Edmund V Capparelli; Kathleen M Brown; Cheryl W Vance; Kathleen Lillis; Prashant Mahajan; Richard Lichenstein; Rachel M Stanley; Colleen O Davis; Stephen Gordon; Jill M Baren; John N van den Anker
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

Review 2.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 3.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

4.  Unaltered serum propranolol binding by meal-induced variations in fatty acids.

Authors:  C A Naranjo; E M Sellers; V Khouw
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Propranolol disposition in renal failure.

Authors:  A J Wood; R E Vestal; C L Spannuth; W J Stone; G R Wilkinson; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

7.  Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration.

Authors:  Zenichi Masuda; Yuji Kurosaki; Kozo Ishino; Keita Yamauchi; Shunji Sano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

Review 8.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  Valproic acid and diazepam interaction in vivo.

Authors:  S Dhillon; A Richens
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.